These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 26770036

  • 1. Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer.
    Hong JH, Kim HH, Han EJ, Byun JH, Jang HS, Choi EK, Kang JH, Yoo IeR.
    J Korean Med Sci; 2016 Jan; 31(1):39-46. PubMed ID: 26770036
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
    Ryu IS, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
    Hofheinz F, Li Y, Steffen IG, Lin Q, Lili C, Hua W, van den Hoff J, Zschaeck S.
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
    Shim SH, Kim DY, Lee DY, Lee SW, Park JY, Lee JJ, Kim JH, Kim YM, Kim YT, Nam JH.
    BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH, Cho A, Yun M, Choi YD, Rha SY, Kang WJ.
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL, Liang JH, Wang L, Xu W, Ding CY.
    Zhonghua Zhong Liu Za Zhi; 2019 Nov 23; 41(11):831-836. PubMed ID: 31770850
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.
    Eur J Nucl Med Mol Imaging; 2015 Aug 23; 42(9):1353-61. PubMed ID: 26067088
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S, Penney BC, Zhang H, Suzuki K, Pu Y.
    Acad Radiol; 2012 Jan 23; 19(1):69-77. PubMed ID: 22142679
    [Abstract] [Full Text] [Related]

  • 17. Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy.
    Nakajo M, Jinguji M, Nakabeppu Y, Nakajo M, Higashi R, Fukukura Y, Sasaki K, Uchikado Y, Natsugoe S, Yoshiura T.
    Eur J Nucl Med Mol Imaging; 2017 Feb 23; 44(2):206-214. PubMed ID: 27613542
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
    Moon SH, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, Lee KH, Kim BT, Choi JY.
    J Nucl Med; 2014 May 23; 55(5):743-8. PubMed ID: 24700884
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ, Lee JJ, Park JY, Kim JH, Kim YM, Kim YT, Nam JH.
    J Gynecol Oncol; 2017 Jul 23; 28(4):e43. PubMed ID: 28541634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.